Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Cancer cell (dividing)
[{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e46/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e46/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e45/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e45/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e44/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e44/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e43/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e43/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e42/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e42/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e41/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e41/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e40/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e40/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e3f/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e3f/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e3e/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e3e/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e3d/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e3d/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e3c/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e3c/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e3b/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e3b/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e3a/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e3a/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e39/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e39/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e38/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e38/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e37/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e37/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e36/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e36/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e35/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e35/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e34/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e34/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e33/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e33/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e32/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e32/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e31/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e31/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e30/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e30/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e2f/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e2f/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e2e/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e2e/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e2d/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e2d/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e2c/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e2c/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e2b/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e2b/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e2a/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e2a/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e29/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e29/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e28/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e28/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e27/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e27/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e26/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e26/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e25/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e25/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e24/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e24/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e23/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e23/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e22/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e22/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e21/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e21/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e20/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e20/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e1f/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e1f/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e1e/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e1e/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e1d/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e1d/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e1c/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e1c/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e1b/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e1b/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e1a/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e1a/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e19/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e19/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e18/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e18/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e17/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e17/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e16/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e16/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e15/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e15/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e14/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e14/615373c2e75ac20029699f71.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ff5baa87c30029843e13/615373c2e75ac20029699f71.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ff5baa87c30029843e13/615373c2e75ac20029699f71.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
cancer,oncology,carcinoma,leukaemia,leukemia,lymphoma,sarcoma,mesothelioma,myeloma,proliferation,proliferating,metastasis,dividing,division,duplication,duplicating,internalcellupdate-high-impact-21q3,cancer cell,tumor cell,tumour cell
Image types
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
